Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT Academic Article uri icon

Overview

MeSH Major

  • Alanine Transaminase
  • Hepatitis C, Chronic
  • Interferon-alpha
  • Ribavirin

abstract

  • Patients with normal ALT had a rate of SVR comparable to that reported in patients with elevated ALT. Higher dose of interferon tended to be more effective in genotype 1 infected patients. De novo ALT elevations were transient and not clinically significant. Patients with CHC should not be excluded from treatment on the basis of ALT alone. Combination therapy with pegylated interferon and ribavirin should be evaluated in these patients.

publication date

  • September 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/j.1572-0241.2004.30049.x

PubMed ID

  • 15330905

Additional Document Info

start page

  • 1700

end page

  • 5

volume

  • 99

number

  • 9